Abstract:Extracellular micro- and nanoscale membrane vesicles produced by different cells progressively attract the attention of the scientific community. They function as mediators of intercellular communication and transport genetic material and signaling molecules between the cells. In the context of keeping homeostasis, the extracellular vesicles contribute to the regulation of various systemic and local processes. Vesicles released by the tumor and activated stromal cells exhibit multiple functions including support of tumor growth, preparation of the pre-metastatic niches, and immune suppression. Considerable progress has been made regarding the criteria of classification of the vesicles according to their origin, content, and function: Exosomes, microvesicles, also referred to as microparticles or ectosomes, and large oncosomes were defined as actively released vesicles. Additionally, apoptotic bodies represented by a highly heterogeneous population of particles produced during apoptosis, the programmed cell death, should be considered. Because the majority of isolation techniques do not allow the separation of different types of vesicles, a joined term "extracellular vesicles" (EVs) was recommended by the ISEV community for the definition of vesicles isolated from either the cell culture supernatants or the body fluids. Because EV content reflects the content of the cell of origin, multiple studies on EVs from body fluids in the context of cancer diagnosis, prediction, and prognosis were performed, actively supporting their high potential as a biomarker source. Here, we review the leading achievements in EV analysis from body fluids, defined as EV-based liquid biopsy, and provide an overview of the main EV constituents: EV surface proteins, intravesicular soluble proteins, EV RNA including mRNA and miRNA, and EV DNA as potential biomarkers. Furthermore, we discuss recent developments in technology for quantitative EV analysis in the clinical setting and future perspectives toward miniaturized high-precision liquid biopsy approaches.

Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis.

Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors

Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy

Diagnostic potential of exosomal extracellular vesicles in oncology

Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy

Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection

Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence

Exosomes as a new frontier of cancer liquid biopsy

The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA

Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine

Application of exosomes as liquid biopsy in clinical diagnosis

Complex RNA World in Small Extracellular Vesicles for Liquid Biopsy in Cancer Management

Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine

Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics

Extracellular Vesicles for Childhood Cancer Liquid Biopsy

Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression

Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis

Extracellular Vesicles: from Bench to Bedside

Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Harnessing microRNA-enriched extracellular vesicles for liquid biopsy